cetuximab,afatinib,pembrolizumab,adagrasib
mirati,boehringer ingelheim,eli lilly,merck
['krystal-1', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'adagrasib']
krystal-1: promising activity and efficacy of adagrasib+/-cetux in heavily pretreated kras g12c #mcrc #esmo22 
Research Fellow @myESMO @TheChristieNHS #CPOClab | Medical Oncologist @COBLH | PhD candidate @syd_health @GarvanInstitute | Traveller, Hiker | Opinions my own